You are correct.
Straight from the insiders mouth to me............ ‘the president of Aegis and I have been working hand in hand for past 3 months of audit. He likes what he sees.’
He likes what he sees to the tune of $23,000,000.00. Now us as investors need to see the fine print of the deal to verify it’s a good deal for us but remember earlier this years the 20+ million to insiders? That is their pay for all their work for years and years and years. They will protect this SS because it’s their wealth on the line just as much as ours.
Furthermore, the company has more than just Covid, cancer and mRNA that will be released soon....... imo.
The company was literally ‘sick to their stomachs’ when they released the mRNA news and it got sold off. They said ‘never again’. They have to get out of the gutter that is pink. And just like Rosen said ‘if a RS is needed to get onto Nasdaq then so be it because it will RS and STAY at its RS’.
In regards to Nasdaq RS...... I believe they will get price up to a buck or more prior. Then potentially a RS of 5 to 1 or something like that. Yes, it will stick because the news once on Nasdaq will blow this up, hopefully to Billion+ and stick.
It’s going to change many investors lives. Won’t be easy in the near future to see through a lot of the minutia but in the end it will be rewarding IMO. Very very rewarding.
I think we are sitting on a goldmine, oil field, diamond mine and a few other precious things.
Market Data 
Markets 
AI
